Second malignancy--a rare phenomenon.

Second malignancy--a rare phenomenon. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Second malignancy--a rare phenomenon. Abstract Text:

I Mehdi,

Second malignancy--a rare phenomenon. Publishing Authors By Initials

I Mehdi,

For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

PUBMED ID PMID:

MEDLINE DATE:

Second malignancy--a rare phenomenon. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: JPMA. The Journal of the Pakistan Medical Associat

VOLUME: 48

Page Numbers: 345-7

Journal Abbreviation:

ISSN: 0030-9982

DAY: 12

MONTH: Nov

YEAR: 1998

Second malignancy--a rare phenomenon. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7501162

Second malignancy--a rare phenomenon. Keywords Mesh Terms:

KEYWORDS: Time Factors

MESH TERMS: epidemiology

Chemical & Substance for Abstract: Second malignancy--a rare phenomenon. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Second malignancy--a rare phenomenon.

AFFILIATION: Pakistan Medical Research Council, PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi.

Country: PAKISTAN

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Pak Med Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Second malignancy--a rare phenomenon Related Publications

• Aborted sudden nocturnal cardiac death in a young man with structurally normal heart.
• Adult non-Hodgkin's lymphoma.
• Breast carcinoma: treat or overtreat.
• Cancer chemo-prevention--pragmatic or over-optimistic.
• Early detection of prostate cancer.
• Effects and a dose response relationship of physical activity to high density lipoprotein cholesterol and body mass index among Saudis.
• Frequency of gastrointestinal tumours at a teaching hospital in Karachi.
• Fungal infections in malignancy.
• Gastrointestinal malignant tumours: are they increasing?
• Haemoperitoneum associated with cocaine abuse: a case report.
• Locally produced drugs need quality control.
• Metastatic prostate cancer.
• Non-small cell lung cancer(NSCLC)--spectrum, management and prospects.
• Pediatric cancers.
• Second malignancy--a chance or probability!
• Second malignancy--a rare phenomenon.
• Serum tumor markers: diagnostic or para-diagnostic.
• Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype.
• Testicular tumors. Multi-disciplinary approach and follow up.